Organigram Inc.

Organigram Global Inc. is a cannabis company. The business has a facility in Moncton.

Business

Organigram is a Canadian company that produces and sells cannabis and cannabis-derived products, including dried flower, pre-rolls, vapes, concentrates, oils, and edibles, for both the adult-use and medical markets.
The company generates revenue through sales to provincial cannabis boards, direct sales to medical patients, and exports and partnerships in certain international markets.

History

On March 24th, 2025, Organigram investors approved rebranding from Organigram Holdings to Organigram Global.
In 2023, the company reported a quarterly profit of $5.3 million, reversing a $1.3 million loss a year earlier, as revenue rose to $43.3 million from $30.4 million and margins improved.
In November 2025, the company announced that James Yamanaka, a former executive at British American Tobacco, was being appointed CEO effective around January 15, 2026, and that he would also join the company’s board.